Similarity Score |
Similarity Level |
Drug ID |
Developmental Stage |
0.9341 |
High Similarity |
NPD7074 |
Phase 3 |
0.9341 |
High Similarity |
NPD7472 |
Approved |
0.929 |
High Similarity |
NPD7808 |
Phase 3 |
0.9281 |
High Similarity |
NPD7054 |
Approved |
0.9118 |
High Similarity |
NPD7251 |
Discontinued |
0.9059 |
High Similarity |
NPD6797 |
Phase 2 |
0.8994 |
High Similarity |
NPD3818 |
Discontinued |
0.8953 |
High Similarity |
NPD4338 |
Clinical (unspecified phase) |
0.8855 |
High Similarity |
NPD4381 |
Clinical (unspecified phase) |
0.883 |
High Similarity |
NPD7804 |
Clinical (unspecified phase) |
0.8655 |
High Similarity |
NPD6166 |
Phase 2 |
0.8655 |
High Similarity |
NPD6168 |
Clinical (unspecified phase) |
0.8655 |
High Similarity |
NPD6167 |
Clinical (unspecified phase) |
0.8563 |
High Similarity |
NPD2801 |
Approved |
0.8529 |
High Similarity |
NPD5494 |
Approved |
0.8503 |
High Similarity |
NPD1934 |
Approved |
0.8402 |
Intermediate Similarity |
NPD3817 |
Phase 2 |
0.8343 |
Intermediate Similarity |
NPD2393 |
Clinical (unspecified phase) |
0.8305 |
Intermediate Similarity |
NPD7993 |
Clinical (unspecified phase) |
0.8274 |
Intermediate Similarity |
NPD4380 |
Phase 2 |
0.8246 |
Intermediate Similarity |
NPD4868 |
Clinical (unspecified phase) |
0.8187 |
Intermediate Similarity |
NPD5402 |
Approved |
0.8156 |
Intermediate Similarity |
NPD6559 |
Discontinued |
0.8152 |
Intermediate Similarity |
NPD7879 |
Clinical (unspecified phase) |
0.814 |
Intermediate Similarity |
NPD3882 |
Suspended |
0.8129 |
Intermediate Similarity |
NPD7819 |
Suspended |
0.8129 |
Intermediate Similarity |
NPD7096 |
Clinical (unspecified phase) |
0.8092 |
Intermediate Similarity |
NPD7075 |
Discontinued |
0.809 |
Intermediate Similarity |
NPD5844 |
Phase 1 |
0.8066 |
Intermediate Similarity |
NPD8312 |
Approved |
0.8066 |
Intermediate Similarity |
NPD8313 |
Approved |
0.8024 |
Intermediate Similarity |
NPD1511 |
Approved |
0.7965 |
Intermediate Similarity |
NPD6801 |
Discontinued |
0.7946 |
Intermediate Similarity |
NPD8397 |
Clinical (unspecified phase) |
0.7941 |
Intermediate Similarity |
NPD1653 |
Approved |
0.7929 |
Intermediate Similarity |
NPD1512 |
Approved |
0.7927 |
Intermediate Similarity |
NPD2796 |
Approved |
0.7882 |
Intermediate Similarity |
NPD6980 |
Clinical (unspecified phase) |
0.7874 |
Intermediate Similarity |
NPD8443 |
Clinical (unspecified phase) |
0.7857 |
Intermediate Similarity |
NPD7685 |
Pre-registration |
0.7833 |
Intermediate Similarity |
NPD7228 |
Approved |
0.7833 |
Intermediate Similarity |
NPD3751 |
Discontinued |
0.7831 |
Intermediate Similarity |
NPD1549 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD7783 |
Phase 2 |
0.7817 |
Intermediate Similarity |
NPD7782 |
Clinical (unspecified phase) |
0.7816 |
Intermediate Similarity |
NPD8455 |
Phase 2 |
0.7816 |
Intermediate Similarity |
NPD1465 |
Phase 2 |
0.7811 |
Intermediate Similarity |
NPD6799 |
Approved |
0.7809 |
Intermediate Similarity |
NPD3787 |
Discontinued |
0.7806 |
Intermediate Similarity |
NPD8151 |
Discontinued |
0.7803 |
Intermediate Similarity |
NPD7411 |
Suspended |
0.7778 |
Intermediate Similarity |
NPD7473 |
Discontinued |
0.7778 |
Intermediate Similarity |
NPD5403 |
Approved |
0.7771 |
Intermediate Similarity |
NPD1552 |
Clinical (unspecified phase) |
0.7771 |
Intermediate Similarity |
NPD1550 |
Clinical (unspecified phase) |
0.7765 |
Intermediate Similarity |
NPD5401 |
Approved |
0.7765 |
Intermediate Similarity |
NPD4378 |
Clinical (unspecified phase) |
0.776 |
Intermediate Similarity |
NPD7240 |
Approved |
0.7753 |
Intermediate Similarity |
NPD6959 |
Discontinued |
0.7753 |
Intermediate Similarity |
NPD7199 |
Phase 2 |
0.7753 |
Intermediate Similarity |
NPD1247 |
Approved |
0.7732 |
Intermediate Similarity |
NPD7698 |
Approved |
0.7732 |
Intermediate Similarity |
NPD7696 |
Phase 3 |
0.7732 |
Intermediate Similarity |
NPD7697 |
Approved |
0.7709 |
Intermediate Similarity |
NPD6232 |
Discontinued |
0.7688 |
Intermediate Similarity |
NPD8055 |
Clinical (unspecified phase) |
0.7668 |
Intermediate Similarity |
NPD6781 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6776 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6780 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6782 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6777 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6778 |
Approved |
0.7668 |
Intermediate Similarity |
NPD6779 |
Approved |
0.7665 |
Intermediate Similarity |
NPD7701 |
Phase 2 |
0.7661 |
Intermediate Similarity |
NPD7410 |
Clinical (unspecified phase) |
0.7651 |
Intermediate Similarity |
NPD1510 |
Phase 2 |
0.7644 |
Intermediate Similarity |
NPD6599 |
Discontinued |
0.7641 |
Intermediate Similarity |
NPD7435 |
Discontinued |
0.7624 |
Intermediate Similarity |
NPD7852 |
Clinical (unspecified phase) |
0.7602 |
Intermediate Similarity |
NPD7870 |
Phase 2 |
0.7602 |
Intermediate Similarity |
NPD7871 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD3926 |
Phase 2 |
0.7569 |
Intermediate Similarity |
NPD7184 |
Clinical (unspecified phase) |
0.7565 |
Intermediate Similarity |
NPD7699 |
Phase 2 |
0.7565 |
Intermediate Similarity |
NPD7700 |
Phase 2 |
0.7557 |
Intermediate Similarity |
NPD37 |
Approved |
0.7542 |
Intermediate Similarity |
NPD919 |
Approved |
0.7528 |
Intermediate Similarity |
NPD4967 |
Phase 2 |
0.7528 |
Intermediate Similarity |
NPD4966 |
Approved |
0.7528 |
Intermediate Similarity |
NPD4965 |
Approved |
0.7525 |
Intermediate Similarity |
NPD7584 |
Approved |
0.75 |
Intermediate Similarity |
NPD6823 |
Phase 2 |
0.75 |
Intermediate Similarity |
NPD7875 |
Clinical (unspecified phase) |
0.75 |
Intermediate Similarity |
NPD7874 |
Approved |
0.747 |
Intermediate Similarity |
NPD1933 |
Approved |
0.7463 |
Intermediate Similarity |
NPD7801 |
Approved |
0.7456 |
Intermediate Similarity |
NPD7266 |
Discontinued |
0.7444 |
Intermediate Similarity |
NPD6234 |
Discontinued |
0.743 |
Intermediate Similarity |
NPD7768 |
Phase 2 |
0.7427 |
Intermediate Similarity |
NPD1878 |
Clinical (unspecified phase) |
0.741 |
Intermediate Similarity |
NPD1240 |
Approved |
0.7409 |
Intermediate Similarity |
NPD6535 |
Approved |
0.7409 |
Intermediate Similarity |
NPD6534 |
Approved |
0.7399 |
Intermediate Similarity |
NPD6143 |
Clinical (unspecified phase) |
0.7368 |
Intermediate Similarity |
NPD8434 |
Phase 2 |
0.736 |
Intermediate Similarity |
NPD6844 |
Discontinued |
0.7337 |
Intermediate Similarity |
NPD8320 |
Phase 1 |
0.7337 |
Intermediate Similarity |
NPD8319 |
Approved |
0.7326 |
Intermediate Similarity |
NPD4628 |
Phase 3 |
0.7326 |
Intermediate Similarity |
NPD3750 |
Approved |
0.7321 |
Intermediate Similarity |
NPD1607 |
Approved |
0.7305 |
Intermediate Similarity |
NPD943 |
Approved |
0.7305 |
Intermediate Similarity |
NPD1612 |
Clinical (unspecified phase) |
0.7305 |
Intermediate Similarity |
NPD1613 |
Approved |
0.7294 |
Intermediate Similarity |
NPD2935 |
Discontinued |
0.7293 |
Intermediate Similarity |
NPD3749 |
Approved |
0.7289 |
Intermediate Similarity |
NPD6859 |
Clinical (unspecified phase) |
0.7277 |
Intermediate Similarity |
NPD8150 |
Discontinued |
0.7273 |
Intermediate Similarity |
NPD920 |
Approved |
0.7262 |
Intermediate Similarity |
NPD447 |
Suspended |
0.7245 |
Intermediate Similarity |
NPD8090 |
Clinical (unspecified phase) |
0.7235 |
Intermediate Similarity |
NPD3748 |
Approved |
0.7222 |
Intermediate Similarity |
NPD7501 |
Clinical (unspecified phase) |
0.7209 |
Intermediate Similarity |
NPD970 |
Clinical (unspecified phase) |
0.7191 |
Intermediate Similarity |
NPD7458 |
Discontinued |
0.7184 |
Intermediate Similarity |
NPD6190 |
Approved |
0.7179 |
Intermediate Similarity |
NPD6213 |
Phase 3 |
0.7179 |
Intermediate Similarity |
NPD6214 |
Clinical (unspecified phase) |
0.7179 |
Intermediate Similarity |
NPD6212 |
Phase 3 |
0.7178 |
Intermediate Similarity |
NPD7583 |
Approved |
0.7168 |
Intermediate Similarity |
NPD7421 |
Clinical (unspecified phase) |
0.7168 |
Intermediate Similarity |
NPD6674 |
Discontinued |
0.716 |
Intermediate Similarity |
NPD230 |
Phase 1 |
0.7159 |
Intermediate Similarity |
NPD642 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD8155 |
Clinical (unspecified phase) |
0.7143 |
Intermediate Similarity |
NPD7585 |
Approved |
0.7126 |
Intermediate Similarity |
NPD3027 |
Phase 3 |
0.7114 |
Intermediate Similarity |
NPD7680 |
Approved |
0.7095 |
Intermediate Similarity |
NPD3226 |
Approved |
0.7093 |
Intermediate Similarity |
NPD1551 |
Phase 2 |
0.7088 |
Intermediate Similarity |
NPD5353 |
Approved |
0.7085 |
Intermediate Similarity |
NPD7237 |
Clinical (unspecified phase) |
0.7083 |
Intermediate Similarity |
NPD2313 |
Discontinued |
0.7081 |
Intermediate Similarity |
NPD8127 |
Discontinued |
0.7069 |
Intermediate Similarity |
NPD1243 |
Approved |
0.7066 |
Intermediate Similarity |
NPD6832 |
Phase 2 |
0.7066 |
Intermediate Similarity |
NPD1529 |
Clinical (unspecified phase) |
0.7062 |
Intermediate Similarity |
NPD2533 |
Approved |
0.7062 |
Intermediate Similarity |
NPD2532 |
Approved |
0.7062 |
Intermediate Similarity |
NPD2534 |
Approved |
0.7059 |
Intermediate Similarity |
NPD7784 |
Clinical (unspecified phase) |
0.7053 |
Intermediate Similarity |
NPD5953 |
Discontinued |
0.7052 |
Intermediate Similarity |
NPD2346 |
Discontinued |
0.7048 |
Intermediate Similarity |
NPD2798 |
Approved |
0.7045 |
Intermediate Similarity |
NPD643 |
Clinical (unspecified phase) |
0.7037 |
Intermediate Similarity |
NPD7286 |
Phase 2 |
0.7035 |
Intermediate Similarity |
NPD2799 |
Discontinued |
0.7006 |
Intermediate Similarity |
NPD1530 |
Clinical (unspecified phase) |
0.7005 |
Intermediate Similarity |
NPD5242 |
Approved |
0.6979 |
Remote Similarity |
NPD7549 |
Discontinued |
0.6977 |
Remote Similarity |
NPD8059 |
Phase 3 |
0.6977 |
Remote Similarity |
NPD8058 |
Clinical (unspecified phase) |
0.6974 |
Remote Similarity |
NPD6841 |
Approved |
0.6974 |
Remote Similarity |
NPD6842 |
Approved |
0.6974 |
Remote Similarity |
NPD6843 |
Phase 3 |
0.6971 |
Remote Similarity |
NPD2800 |
Approved |
0.6966 |
Remote Similarity |
NPD7004 |
Clinical (unspecified phase) |
0.6951 |
Remote Similarity |
NPD1547 |
Clinical (unspecified phase) |
0.6936 |
Remote Similarity |
NPD7033 |
Discontinued |
0.6923 |
Remote Similarity |
NPD6386 |
Approved |
0.6923 |
Remote Similarity |
NPD6385 |
Approved |
0.6897 |
Remote Similarity |
NPD5006 |
Approved |
0.6897 |
Remote Similarity |
NPD6099 |
Approved |
0.6897 |
Remote Similarity |
NPD6100 |
Approved |
0.6897 |
Remote Similarity |
NPD5005 |
Approved |
0.6891 |
Remote Similarity |
NPD4419 |
Clinical (unspecified phase) |
0.6884 |
Remote Similarity |
NPD4360 |
Phase 2 |
0.6884 |
Remote Similarity |
NPD4363 |
Phase 3 |
0.6879 |
Remote Similarity |
NPD7097 |
Phase 1 |
0.6878 |
Remote Similarity |
NPD7211 |
Clinical (unspecified phase) |
0.6875 |
Remote Similarity |
NPD1652 |
Phase 2 |
0.686 |
Remote Similarity |
NPD1899 |
Clinical (unspecified phase) |
0.6857 |
Remote Similarity |
NPD2344 |
Approved |
0.6848 |
Remote Similarity |
NPD1091 |
Approved |
0.6842 |
Remote Similarity |
NPD6233 |
Phase 2 |
0.6839 |
Remote Similarity |
NPD651 |
Clinical (unspecified phase) |
0.6837 |
Remote Similarity |
NPD5619 |
Clinical (unspecified phase) |
0.6836 |
Remote Similarity |
NPD6398 |
Clinical (unspecified phase) |
0.6832 |
Remote Similarity |
NPD8285 |
Discontinued |
0.6831 |
Remote Similarity |
NPD7615 |
Clinical (unspecified phase) |
0.6821 |
Remote Similarity |
NPD6651 |
Approved |
0.6816 |
Remote Similarity |
NPD7390 |
Discontinued |
0.6813 |
Remote Similarity |
NPD5808 |
Clinical (unspecified phase) |
0.6805 |
Remote Similarity |
NPD9494 |
Approved |
0.6784 |
Remote Similarity |
NPD6798 |
Discontinued |
0.6782 |
Remote Similarity |
NPD4420 |
Approved |
0.6777 |
Remote Similarity |
NPD7930 |
Approved |
0.6772 |
Remote Similarity |
NPD7229 |
Phase 3 |
0.6765 |
Remote Similarity |
NPD4908 |
Phase 1 |
0.6763
|
Remote Similarity |
NPD5123 |
Clinical (unspecified phase) |